Corporate Updates - 18 December, 2019

Sai Life Sciences appoints new Chief Business Officer

Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the appointment of Jay Stella as Chief Business Officer

#jaystellajoins #sailifesciences #aschiefbusinessofficer #medicircle

Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for the company. Jay will be based out of Cambridge, Massachusetts, United States and report to the CEO & Managing Director, Krishna Kanumuri.

Jay Stella brings over 25 years of leadership in the pharmaceutical and medical devices industries with extensive experience across R&D, manufacturing, business development, finance, and post-M&A integrations. He held positions of increasing responsibility at Millennium Pharmaceuticals and Takeda Pharmaceuticals for 15 years, across strategy & operations, business development, and integrations & divestitures, while also gaining significant experience in the Japanese culture and business environment. Earlier, he worked for medium-sized biotech companies, Biogen and Genetics Institute, where he held various financial and operational roles. Prior to the pharmaceutical industry, Jay worked in technical operations, manufacturing, planning, and strategic sourcing roles in the medical device industry. Jay received his MBA from Boston University and his Baccalaureate degree from the University of Vermont in Spanish with minors in Chemistry and Biology. 

Making the announcement, Krishna Kanumuri said, "Inducting top-notch global leadership and scientific talent is a key priority as part of our transformative effort, Sai Nxt. We are delighted to have Jay on board in this exciting phase."

Sai Nxt is an organization-wide initiative aimed at transforming the company into a new generation CDMO. With investments of over US $ 150 million between 2019 and 2023, the focus is on three key areas – People & culture, Processes & automation, Infrastructure & scientific capabilities.

Team Medicircle

Related Stories

-Advertisements-



Trending Now

Right to protein reaches MumbaiFebruary 05, 2020
Bold Run by Niine Sanitary Napkins February 05, 2020
Patient Safety Movement Foundation Urges to Support for Data SharingFebruary 05, 2020
Jabil Launches Jabil Healthcare, the Largest Healthcare Manufacturing Solutions ProviderFebruary 05, 2020
On World Cancer Day Merck Foundation takes new resolution for treating OncologyFebruary 05, 2020
Coronavirus Maharashtra Update : 107 passengers screened, one person each in Pune and Miraj under observationFebruary 05, 2020
Dr.Batra's Clinics is Distributing Free Preventive Homeopathic DosesFebruary 05, 2020
Bajaj Finserv SuperCard : A One-stop Shop for Exclusive Travel DealsFebruary 05, 2020
National STEM Awards 2020 : Government Schools to Battle it out at India's first National STEM ChallengeFebruary 05, 2020
Saudi Arabia has reported an outbreak of the highly pathogenic H5N8 bird flu virus on a poultry farmFebruary 05, 2020
Daily Horoscope, 5 February 2020February 05, 2020
GOI outlines the milestones achieved : National Population Policy February 04, 2020
On World Cancer Day, Medicircle catches up with Dr Rajas B Patel to understand the trends and challenges of the diseaseFebruary 04, 2020
On World Cancer Day, Manipal Hospitals Bangalore, Pledge for a Cancer-free FutureFebruary 04, 2020
GOI clarified Precautionary measures advised by Ministry of AYUSH in the context of Corona VirusFebruary 04, 2020
Indian Bio-Pharmaceuticals Industry poised for growth : INR 2891.70 Billion Between 2018-2023February 04, 2020
IIM Calcutta to Offer Post-Graduate Certificate in Healthcare Management February 04, 2020
Nanavati Super Speciality Hospital survey : Young India unaware of Cervical and Breast cancers February 04, 2020
GCPL and HICA Join Hands for an Initiative to Promote Plastic Waste Disposal of Household Insecticide ProductsFebruary 04, 2020
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target TherapiesFebruary 04, 2020